Literature DB >> 1739568

Maternal and fetal haemodynamic effects of spinal and extradural anaesthesia for elective caesarean section.

S C Robson1, R J Boys, C Rodeck, B Morgan.   

Abstract

Serial haemodynamic investigations were performed in 32 women who were allocated randomly to receive either spinal or extradural anaesthesia for elective Caesarean section. Cardiac output was measured by Doppler and cross-sectional echocardiography at the aortic valve. Doppler flow velocity waveforms were recorded also from the umbilical artery. Preloading with Ringer lactate solution 1 litre increased cardiac output in both groups. After injection of bupivacaine, cardiac output remained increased in the extradural group, but decreased in the spinal group. This was associated with an increase in umbilical artery pulsatility index in the spinal group. Umbilical artery pH was less in the spinal group (7.22 vs 7.27), although no neonate was depressed at birth. The maximum percentage change in cardiac output and umbilical artery pulsatility index correlated with umbilical artery pH (r = 0.54, r = 0.72, respectively). There was no significant correlation with change in arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739568     DOI: 10.1093/bja/68.1.54

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  25 in total

1.  Reducing aortocaval compression: how much tilt is enough?

Authors:  S M Kinsella; J G Whitwam; J A Spencer
Journal:  BMJ       Date:  1992-09-05

2.  The effect of 0.5 L 6% hydroxyethyl starch 130/0.42 versus 1 L Ringer's lactate preload on the hemodynamic status of parturients undergoing spinal anesthesia for elective cesarean delivery using arterial pulse contour analysis.

Authors:  Paraskevi Matsota; Agathi Karakosta; Ageliki Pandazi; Dimitra Niokou; Kalliopi Christodoulaki; Georgia Kostopanagiotou
Journal:  J Anesth       Date:  2014-09-30       Impact factor: 2.078

Review 3.  [Recent standards in management of obstetric anesthesia].

Authors:  Maximiliaan van Erp; Clemens Ortner; Stefan Jochberger; Klaus Ulrich Klein
Journal:  Wien Med Wochenschr       Date:  2017-07-25

4.  Clinical evaluation of the flotrac/Vigileo system for continuous cardiac output monitoring in patients undergoing regional anesthesia for elective cesarean section: a pilot study.

Authors:  José Otavio Costa Auler; Marcelo L A Torres; Mônica M Cardoso; Thais C Tebaldi; André P Schmidt; Mario M Kondo; Marcelo Zugaib
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 5.  Spinal anaesthesia in obstetrics.

Authors:  P Morgan
Journal:  Can J Anaesth       Date:  1995-12       Impact factor: 5.063

6.  Table Tilt Versus Pelvic Tilt Position for Intrauterine Resuscitation during Spinal Anaesthesia for Caesarian Section.

Authors:  Shahla Haleem; Neeraj K Singh; Shyam Bhandari; Dheeraj Sharma; S Hussain Amir
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

7.  Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study.

Authors:  Jin-Ping Liu; Zheng-Bin Pan; Miao Zhu; Guo-Wei Zhu; Da-Bing Song; Xin-Zhong Chen; Xiao-Wei Qian
Journal:  Drug Des Devel Ther       Date:  2021-09-07       Impact factor: 4.162

8.  Techniques for preventing hypotension during spinal anaesthesia for caesarean section.

Authors:  Cheryl Chooi; Julia J Cox; Richard S Lumb; Philippa Middleton; Mark Chemali; Richard S Emmett; Scott W Simmons; Allan M Cyna
Journal:  Cochrane Database Syst Rev       Date:  2020-07-01

Review 9.  Spinal versus epidural anaesthesia for caesarean section.

Authors:  K Ng; J Parsons; A M Cyna; P Middleton
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Blood pressure and cardiac output during caesarean delivery under spinal anaesthesia: a prospective cohort study.

Authors:  Trond Melbye Michelsen; Christian Tronstad; Leiv Arne Rosseland
Journal:  BMJ Open       Date:  2021-06-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.